PHC Holdings Past Earnings Performance
Past criteria checks 3/6
PHC Holdings has been growing earnings at an average annual rate of 26.8%, while the Medical Equipment industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 1.2% per year. PHC Holdings's return on equity is 3.9%, and it has net margins of 1.6%.
Key information
26.80%
Earnings growth rate
25.50%
EPS growth rate
| Medical Equipment Industry Growth | 7.81% |
| Revenue growth rate | 1.25% |
| Return on equity | 3.87% |
| Net Margin | 1.61% |
| Last Earnings Update | 30 Sep 2025 |
Recent past performance updates
Recent updates
An Intrinsic Calculation For PHC Holdings Corporation (TSE:6523) Suggests It's 39% Undervalued
Nov 17
There Is A Reason PHC Holdings Corporation's (TSE:6523) Price Is Undemanding
Sep 06
Digital Healthcare And Precision Diagnostics Will Shape Tomorrow
Key Takeaways Expansion in high-margin diabetes and digital pathology products, plus healthcare IT, positions PHC to benefit from digitalization and recurring service revenues. Investment in R&D and operational streamlining enhances competitiveness and resilience against external risks, supporting sustainable future growth.Statutory Profit Doesn't Reflect How Good PHC Holdings' (TSE:6523) Earnings Are
Feb 19PHC Holdings (TSE:6523) Takes On Some Risk With Its Use Of Debt
Jan 28PHC Holdings Corporation's (TSE:6523) Intrinsic Value Is Potentially 68% Above Its Share Price
Nov 15Does PHC Holdings (TSE:6523) Have A Healthy Balance Sheet?
Aug 09Is PHC Holdings Corporation (TSE:6523) Trading At A 47% Discount?
Jun 08PHC Holdings Corporation's (TSE:6523) Prospects Need A Boost To Lift Shares
Apr 20Revenue & Expenses Breakdown
How PHC Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 25 | 361,105 | 5,826 | 123,871 | 0 |
| 30 Jun 25 | 360,262 | 11,317 | 143,010 | 0 |
| 31 Mar 25 | 361,593 | 10,485 | 125,924 | 0 |
| 31 Dec 24 | 364,127 | 5,900 | 127,643 | 0 |
| 30 Sep 24 | 360,944 | -6,336 | 132,188 | 0 |
| 30 Jun 24 | 357,762 | -12,866 | 132,083 | 0 |
| 31 Mar 24 | 353,900 | -12,893 | 131,507 | 0 |
| 31 Dec 23 | 348,015 | -17,779 | 127,347 | 0 |
| 30 Sep 23 | 352,669 | -6,874 | 121,680 | 0 |
| 30 Jun 23 | 356,257 | 684 | 120,135 | 0 |
| 31 Mar 23 | 356,434 | -3,222 | 121,106 | 0 |
| 31 Dec 22 | 353,186 | -23,570 | 123,223 | 0 |
| 30 Sep 22 | 344,985 | -22,257 | 120,604 | 0 |
| 30 Jun 22 | 341,045 | -25,950 | 122,440 | 0 |
| 31 Mar 22 | 340,452 | -8,460 | 120,362 | 0 |
| 31 Mar 21 | 306,071 | 16,906 | 129,646 | 0 |
| 31 Mar 20 | 272,637 | 5,276 | 123,423 | 0 |
| 31 Mar 19 | 186,546 | 15,453 | 94,235 | 0 |
Quality Earnings: 6523 has high quality earnings.
Growing Profit Margin: 6523 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6523 has become profitable over the past 5 years, growing earnings by 26.8% per year.
Accelerating Growth: 6523 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6523 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3%).
Return on Equity
High ROE: 6523's Return on Equity (3.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 09:55 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PHC Holdings Corporation is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |
| Akinori Ueda | Goldman Sachs |